Cleared Traditional

K161962 - VAMP Venous/Arterial Blood Management P...

K161962 is an FDA 510(k) clearance for VAMP Venous/Arterial Blood Management P..., manufactured by Edwards Lifesciences, LLC. The device is a Class 2 Cardiovascular device with product code KRA cleared through the Traditional 510(k) pathway after a 133-day FDA review.

K161962 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2016
Decision
133d
Days
Class 2
Risk

K161962 is an FDA 510(k) clearance for the VAMP Venous/Arterial Blood Management Protection System. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on November 28, 2016 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

FDA 510(k) Submission Details - K161962

510(k) Number K161962 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2016
Decision Date November 28, 2016
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRA Device Classification - Class 2, Special Controls

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 130
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K161962.
CXI TriForce Peripheral Crossing Set
K170931 · Cook Incorporated · Nov 2017
Maestro Microcatheter
K172081 · Merit Medical Systems, Inc. · Aug 2017
Direxion and Direxion HI-FLO Torqueable Microcatheters
K163701 · Boston Scientific Corporation · May 2017
CXI Support Catheter
K160884 · Cook Incorporated · Nov 2016
SwiftNINJA Microcatheter
K161921 · Merit Medical Systems, Inc. · Nov 2016
CrossCath Support Catheter
K161801 · Cook Incorporated · Jul 2016